IST:MEDTR Statistics

Total Valuation

IST:MEDTR has a market cap or net worth of TRY 3.53 billion. The enterprise value is 3.19 billion.

Market Cap	3.53B
Enterprise Value	3.19B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Jul 28, 2025

Share Statistics

IST:MEDTR has 119.00 million shares outstanding.

Current Share Class	95.38M
Shares Outstanding	119.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	79.45%
Owned by Institutions (%)	10.72%
Float	24.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.69
PB Ratio	1.47
P/TBV Ratio	1.48
P/FCF Ratio	7.02
P/OCF Ratio	5.13
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.07, with an EV/FCF ratio of 6.34.

EV / Earnings	-284.61
EV / Sales	1.52
EV / EBITDA	13.07
EV / EBIT	22.36
EV / FCF	6.34

Financial Position

The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.02.

Current Ratio	3.65
Quick Ratio	2.07
Debt / Equity	0.02
Debt / EBITDA	0.16
Debt / FCF	0.08
Interest Coverage	2.44

Financial Efficiency

Return on equity (ROE) is -0.78% and return on invested capital (ROIC) is 4.59%.

Return on Equity (ROE)	-0.78%
Return on Assets (ROA)	3.71%
Return on Invested Capital (ROIC)	4.59%
Return on Capital Employed (ROCE)	6.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	728
Asset Turnover	0.80
Inventory Turnover	2.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.82% in the last 52 weeks. The beta is 0.47, so IST:MEDTR's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-2.82%
50-Day Moving Average	36.10
200-Day Moving Average	43.39
Relative Strength Index (RSI)	27.90
Average Volume (20 Days)	675,904

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IST:MEDTR had revenue of TRY 2.09 billion and -11.21 million in losses.

Revenue	2.09B
Gross Profit	723.26M
Operating Income	155.88M
Pretax Income	-52.53M
Net Income	-11.21M
EBITDA	256.06M
EBIT	155.88M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 386.70 million in cash and 41.05 million in debt, giving a net cash position of 345.64 million or 2.90 per share.

Cash & Cash Equivalents	386.70M
Total Debt	41.05M
Net Cash	345.64M
Net Cash Per Share	2.90
Equity (Book Value)	2.41B
Book Value Per Share	n/a
Working Capital	1.20B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 688.23 million and capital expenditures -184.85 million, giving a free cash flow of 503.38 million.

Operating Cash Flow	688.23M
Capital Expenditures	-184.85M
Free Cash Flow	503.38M
FCF Per Share	4.23

Full Cash Flow Statement

Margins

Gross margin is 34.55%, with operating and profit margins of 7.45% and -0.54%.

Gross Margin	34.55%
Operating Margin	7.45%
Pretax Margin	-2.51%
Profit Margin	-0.54%
EBITDA Margin	12.23%
EBIT Margin	7.45%
FCF Margin	24.05%

Dividends & Yields

This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 0.99%.

Dividend Per Share	0.29
Dividend Yield	0.99%
Dividend Growth (YoY)	-71.43%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	0.99%
Earnings Yield	-0.32%
FCF Yield	14.25%

Dividend Details

Stock Splits

The last stock split was on February 22, 2022. It was a forward split with a ratio of 3.5.

Last Split Date	Feb 22, 2022
Split Type	Forward
Split Ratio	3.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a